JAMDA Online Original Study| Volume 15, ISSUE 11, P850.e1-850.e9, November 2014

Potentially Inappropriate Drug Prescribing and Associated Factors in Nursing Homes

Published:October 02, 2014DOI:



      Polymedication is frequent in nursing home (NH) residents. This increases the risk of potentially inappropriate drug prescribing (PIDP), which can lead to adverse drug events, such as falls and hospitalization.


      To identify PIDP in NH residents and to investigate subject-related and NH structural and organizational factors associated with PIDP.


      Cross-sectional study.


      A total of 175 NHs in Midi-Pyrénées region, South-Western France.


      A total of 974 subjects randomly selected from the 6275 NH residents participating in the IQUARE study.


      Patients with PIDP.

      Main Outcomes and Measures

      PIDP was the main outcome measure. It was defined using a specific indicator, based on the Summary of Product Characteristics, on the Laroche list, and on residents' clinical data. PIDP was defined as the presence of at least 1 of the following criteria: (1) drug with an unfavorable benefit-to-risk ratio; (2) drug with questionable efficacy according to the Laroche list; (3) absolute contraindication; (4) significant drug-drug interaction. Associated factors were identified by using multivariable logistic regression models.


      Among the 974 residents included, 71% had PIDP. PIDP was more frequent in patients without dementia, with several comorbidities and taking multiple medications. In the multivariable analysis, age (odds ratio [OR] 1.02; 95% confidence interval [CI] 1.01–1.03) and Charlson Comorbidity Index (CCI; P = .003, CCI = 1 versus 0: OR1/0 1.22; 95% CI 0.85–1.74, CCI ≥ 2 versus 0: OR2/0 1.72; 95% CI 1.23–2.41) were associated with an increased likelihood of PIDP. By contrast, dementia was associated with a lower likelihood of PIDP (OR 0.70; 95% CI 0.53–0.94). Among NH structural and organizational characteristics, the access to psychiatric advice and/or to hospitalization in a psychiatric unit (OR 1.36; 95% CI 1.02–1.82) and the presence of a reevaluation of drug prescriptions (OR 1.45; 95% CI 1.07–1.96) were associated with an increased likelihood of PIDP.

      Conclusions and Relevance

      Our work suggests that some NH characteristics are associated with an increased likelihood of PIDP. Gaining a better understanding of the factors influencing PIDP, especially structural and organizational NH factors, can help to determine the interventions that should be implemented.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rolland Y.
        • Aquino J.-P.
        • Andrieu S.
        • et al.
        Identification of the main domains for quality of care and clinical research in nursing homes.
        J Nutr Health Aging. 2011; 15: 410-424
        • Roth M.T.
        • Ivey J.L.
        Self-reported medication use in community-residing older adults: A pilot study.
        Am J Geriatr Pharmacother. 2005; 3: 196-204
        • Fick D.M.
        • Cooper J.W.
        • Wade W.E.
        • et al.
        Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts.
        Arch Intern Med. 2003; 163: 2716-2724
        • Gurwitz J.H.
        • Field T.S.
        • Judge J.
        • et al.
        The incidence of adverse drug events in two large academic long-term care facilities.
        Am J Med. 2005; 118: 251-258
        • Nguyen J.K.
        • Fouts M.M.
        • Kotabe S.E.
        • Lo E.
        Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents.
        Am J Geriatr Pharmacother. 2006; 4: 36-41
        • Tjia J.
        • Gurwitz J.H.
        • Briesacher B.A.
        Challenge of changing nursing home prescribing culture.
        Am J Geriatr Pharmacother. 2012; 10: 37-46
        • Bronskill S.E.
        • Gill S.S.
        • Paterson J.M.
        • et al.
        Exploring variation in rates of polypharmacy across long term care homes.
        J Am Med Dir Assoc. 2012; 13: 309.e15-309.e21
        • Hartikainen S.
        • Lönnroos E.
        • Louhivuori K.
        Medication as a risk factor for falls: Critical systematic review.
        J Gerontol A Biol Sci Med Sci. 2007; 62: 1172-1181
        • Cherubini A.
        • Eusebi P.
        • Dell'Aquila G.
        • et al.
        Predictors of hospitalization in Italian nursing home residents: The U.L.I.S.S.E. project.
        J Am Med Dir Assoc. 2012; 13: 84.e5-84.e10
        • Mallet L.
        • Spinewine A.
        • Huang A.
        The challenge of managing drug interactions in elderly people.
        Lancet. 2007; 370: 185-191
        • Garfinkel D.
        • Mangin D.
        Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: Addressing polypharmacy.
        Arch Intern Med. 2010; 170: 1648-1654
        • Spinewine A.
        • Schmader K.E.
        • Barber N.
        • et al.
        Appropriate prescribing in elderly people: How well can it be measured and optimised?.
        Lancet. 2007; 370: 173-184
        • O'Mahony D.
        • Gallagher P.F.
        Inappropriate prescribing in the older population: Need for new criteria.
        Age Ageing. 2008; 37: 138-141
        • Aparasu R.R.
        • Mort J.R.
        Inappropriate prescribing for the elderly: Beers criteria-based review.
        Ann Pharmacother. 2000; 34: 338-346
        • Dhall J.
        • Larrat E.P.
        • Lapane K.L.
        Use of potentially inappropriate drugs in nursing homes.
        Pharmacotherapy. 2002; 22: 88-96
        • Lau D.T.
        • Kasper J.D.
        • Potter D.E.B.
        • Lyles A.
        Potentially inappropriate medication prescriptions among elderly nursing home residents: Their scope and associated resident and facility characteristics.
        Health Serv Res. 2004; 39: 1257-1276
        • Briesacher B.
        • Limcangco R.
        • Simoni-Wastila L.
        • et al.
        Evaluation of nationally mandated drug use reviews to improve patient safety in nursing homes: A natural experiment.
        J Am Geriatr Soc. 2005; 53: 991-996
        • Zuckerman I.H.
        • Hernandez J.J.
        • Gruber-Baldini A.L.
        • et al.
        Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia.
        Am J Geriatr Pharmacother. 2005; 3: 246-254
        • Hosia-Randell H.M.V.
        • Muurinen S.M.
        • Pitkälä K.H.
        Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: A cross-sectional study.
        Drugs Aging. 2008; 25: 683-692
        • Beers M.H.
        • Ouslander J.G.
        • Rollingher I.
        • et al.
        Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine.
        Arch Intern Med. 1991; 151: 1825-1832
        • O'Mahony D.
        • Gallagher P.
        • Ryan C.
        • et al.
        STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age.
        Eur Geriatr Med. 2010; 1: 45-51
        • Laroche M.-L.
        • Charmes J.-P.
        • Merle L.
        Potentially inappropriate medications in the elderly: A French consensus panel list.
        Eur J Clin Pharmacol. 2007; 63: 725-731
        • Hanlon J.T.
        • Fillenbaum G.G.
        • Kuchibhatla M.
        • et al.
        Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders.
        Med Care. 2002; 40: 166-176
        • Keely J.L.
        • American College of Physicians-American Society of Internal Medicine
        Pharmacist scope of practice.
        Ann Intern Med. 2002; 136: 79-85
        • De Souto Barreto P.
        • Lapeyre-Mestre M.
        • Mathieu C.
        • et al.
        A multicentric individually-tailored controlled trial of education and professional support to nursing home staff: Research protocol and baseline data of the IQUARE study.
        J Nutr Health Aging. 2013; 17: 173-178
        • De Souto Barreto P.
        • Lapeyre-Mestre M.
        • Mathieu C.
        • et al.
        Indicators of benzodiazepine use in nursing home residents in France: A cross-sectional study.
        J Am Med Dir Assoc. 2013; 14: 29-33
        • De Souto Barreto P.
        • Lapeyre-Mestre M.
        • Vellas B.
        • Rolland Y.
        Potential underuse of analgesics for recognized pain in nursing home residents with dementia: A cross-sectional study.
        Pain. 2013; 154: 2427-2431
        • De Souto Barreto P.
        • Lapeyre-Mestre M.
        • Mathieu C.
        • et al.
        Prevalence and associations of the use of proton-pump inhibitors in nursing homes: A cross-sectional study.
        J Am Med Dir Assoc. 2013; 14: 265-269
      1. World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Available at: Accessed January 29, 2014.

      2. Ministère des affaires sociales et de la santé. Base de données publique des médicaments. Available at: Accessed December 13, 2013.

      3. Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM). ANSM: Agence nationale de sécurité du médicament et des produits de santé. Available at: Accessed December 13, 2013.

      4. Haute Autorité de Santé (HAS). Recommandations de bonnes pratique clinique chez les personnes âgées. Available at: Accessed December 13, 2013.

        • Hox J.J.
        Applied Multilevel Analysis.
        TT-Publikaties, Amsterdam, The Netherlands1995
      5. Hosmer J, David W, Lemeshow S, Sturdivant RX. Model-Building Strategies and Methods for Logistic Regression. In: Applied Logistic Regression. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2013:89-151. Available at: Accessed September 13, 2014.

        • Hosmer D.W.
        • Hosmer T.
        • Le Cessie S.
        • Lemeshow S.
        A comparison of goodness-of-fit tests for the logistic regression model.
        Stat Med. 1997; 16: 965-980
        • Hughes C.M.
        • Lapane K.L.
        • Mor V.
        Influence of facility characteristics on use of antipsychotic medications in nursing homes.
        Med Care. 2000; 38: 1164-1173
        • Rochon P.A.
        • Stukel T.A.
        • Bronskill S.E.
        • et al.
        Variation in nursing home antipsychotic prescribing rates.
        Arch Intern Med. 2007; 167: 676-683
        • Rolland Y.
        • Abellan van Kan G.
        • Hermabessiere S.
        • et al.
        Descriptive study of nursing home residents from the REHPA network.
        J Nutr Health Aging. 2009; 13: 679-683
        • Lau D.T.
        • Kasper J.D.
        • Potter D.E.B.
        • et al.
        Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents.
        Arch Intern Med. 2005; 165: 68-74
        • Chiang L.
        • Hirsch S.H.
        • Reuben D.B.
        Predictors of medication prescription in nursing homes.
        J Am Med Dir Assoc. 2000; 1: 97-102
        • Hanlon J.T.
        • Schmader K.E.
        • Boult C.
        • et al.
        Use of inappropriate prescription drugs by older people.
        J Am Geriatr Soc. 2002; 50: 26-34
        • Lang P.O.
        • Vogt-Ferrier N.
        • Hasso Y.
        • et al.
        Interdisciplinary geriatric and psychiatric care reduces potentially inappropriate prescribing in the hospital: Interventional study in 150 acutely ill elderly patients with mental and somatic comorbid conditions.
        J Am Med Dir Assoc. 2012; 13: 406.e1-406.e7
        • Lester P.
        • Kohen I.
        • Stefanacci R.G.
        • Feuerman M.
        Antipsychotic drug use since the FDA black box warning: Survey of nursing home policies.
        J Am Med Dir Assoc. 2011; 12: 573-577
      6. Haute Autorité de Santé. Programme AMI-ALZHEIMER: Alerte et Maitrise de l'Iatrogénie des Neuroleptiques dans la maladie d'Alzheimer. Available at: Accessed September 12, 2014.

        • Gallini A.
        • Andrieu S.
        • Donohue J.M.
        • et al.
        Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings.
        Eur Neuropsychopharmacol. 2014; 24: 95-104
        • Brulhart M.I.
        • Wermeille J.P.
        Multidisciplinary medication review: Evaluation of a pharmaceutical care model for nursing homes.
        Int J Clin Pharm. 2011; 33: 549-557
        • Montastruc F.
        • Gardette V.
        • Cantet C.
        • et al.
        Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: Be aware of atropinic and benzodiazepine drugs!.
        Eur J Clin Pharmacol. 2013; 69: 1589-1597
        • Cumming R.G.
        • Le Couteur D.G.
        Benzodiazepines and risk of hip fractures in older people: A review of the evidence.
        CNS Drugs. 2003; 17: 825-837
        • Allain H.
        • Bentué-Ferrer D.
        • Polard E.
        • et al.
        Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: A comparative review.
        Drugs Aging. 2005; 22: 749-765
      7. Bouvenot G. Consumption and prescription of “cerebral vasodilators” in community AFSSAPS. Available at: Accessed February 14, 2014.

        • Sheen E.
        • Triadafilopoulos G.
        Adverse effects of long-term proton pump inhibitor therapy.
        Dig Dis Sci. 2011; 56: 931-950
        • Herzig S.J.
        • Howell M.D.
        • Ngo L.H.
        • Marcantonio E.R.
        Acid-suppressive medication use and the risk for hospital-acquired pneumonia.
        JAMA. 2009; 301: 2120-2128
        • Van der Maarel-Wierink C.D.
        • Vanobbergen J.N.O.
        • Bronkhorst E.M.
        • et al.
        Risk factors for aspiration pneumonia in frail older people: A systematic literature review.
        J Am Med Dir Assoc. 2011; 12: 344-354
        • Abrahamsen B.
        • Eiken P.
        • Eastell R.
        Proton pump inhibitor use and the antifracture efficacy of alendronate.
        Arch Intern Med. 2011; 171: 998-1004
        • Scott S.A.
        • Owusu Obeng A.
        • Hulot J.-S.
        Antiplatelet drug interactions with proton pump inhibitors.
        Expert Opin Drug Metab Toxicol. 2014; 10: 175-189
      8. Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques. Enquête auprès des établissements d'hébergement pour personnes âgées en 2011 (EHPA 2011, DREES) - Premières données - juillet 2013. Available at: Accessed September 13, 2014.